MedPath

Zoledronic Acid

These highlights do not include all the information needed to use ZOLEDRONIC ACID INJECTION safely and effectively. See full prescribing information for ZOLEDRONIC ACID INJECTION. ZOLEDRONIC ACID injection, for intravenous infusion Initial U.S. Approval: 2001

Approved
Approval ID

bf5f96d4-f87c-4968-bed0-a4b5e77f4162

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 2, 2023

Manufacturers
FDA

Eugia US LLC

DUNS: 968961354

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Zoledronic Acid

PRODUCT DETAILS

NDC Product Code55150-283
Application NumberANDA209125
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateMarch 18, 2023
Generic NameZoledronic Acid

INGREDIENTS (4)

ZOLEDRONIC ACIDActive
Quantity: 5 mg in 100 mL
Code: 6XC1PAD3KF
Classification: ACTIM
TRISODIUM CITRATE DIHYDRATEInactive
Code: B22547B95K
Classification: IACT
MANNITOLInactive
Code: 3OWL53L36A
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Zoledronic Acid - FDA Drug Approval Details